Luke Lambourne
lukelambourne.bsky.social
Luke Lambourne
@lukelambourne.bsky.social
Scientist at Dana-Farber Cancer Institute / Harvard Medical School
Reposted by Luke Lambourne
I am happy to finally share this preprint of my PhD project in @guillaumediss.bsky.social lab at the FMI in Basel.
We used ddPCA to map the genetic architecture of the entire human bZIP interaction network.

www.biorxiv.org/content/10.1...

Thanks to all our co-authors for the great collaboration!
The genetic architecture of the human bZIP family
Generative biology holds the promise to transform our ability to design and understand living systems by creating novel proteins, pathways, and organisms with tailored functions that address challenge...
www.biorxiv.org
August 25, 2025 at 3:30 PM
Reposted by Luke Lambourne
Excited to share this collaborative review with @dsegre.bsky.social and @devmoy.bsky.social. We discuss common issues with context-specific genome-scale metabolic network models and provide recommendation for future model development.
August 8, 2025 at 11:04 AM
Reposted by Luke Lambourne
Exited to share our recent work on viral cis-regulatory elements in collaboration with @tewhey.bsky.social!
We identified >2000 CREs across the genomes of 27 human-infecting dsDNA viruses from the Herpesvirus, Adenovirus, Papillomavirus, and Polyomavirus families.
www.biorxiv.org/content/10.1...
1/8
July 24, 2025 at 7:18 PM
Reposted by Luke Lambourne
Variant characterization in the intrinsically disordered human proteome - here is how we did it using short linear motif prediction, AlphaFold, and experimentation. Check out our preprint: www.biorxiv.org/cgi/content/...
Variant characterization in the intrinsically disordered human proteome
Variant effect prediction remains a key challenge to resolve in precision medicine. Sophisticated computational models that exploit sequence conservation and structure are increasingly successful in t...
www.biorxiv.org
July 1, 2025 at 5:34 AM
Reposted by Luke Lambourne
Congrats to Renata Goncalves who led a study in Gokhan Hotamisligil's lab that has just come out in Nature - ably assisted by Jillian Riveros!

www.nature.com/articles/s41...
CoQ imbalance drives reverse electron transport to disrupt liver metabolism - Nature
Reverse electron transport is the mechanism behind excess mitochondrial reactive oxygen species in the livers of obese mice, which has implications for developing therapeutics for fatty liver dis...
www.nature.com
May 29, 2025 at 8:45 AM
Reposted by Luke Lambourne
Reposted by Luke Lambourne
reposting the 🧵 from the other site that I wrote when the preprint came out:

TFs, like most genes, are frequently expressed as a series of multiple distinct isoforms. these isoforms (by definition) differ in sequence -- often in annotated protein domain regions (e.g. DNA-binding & effector domains)
March 26, 2025 at 6:05 PM
The published version of our transcription factor isoforms survey is online

www.sciencedirect.com/science/arti...

we cloned 100's of isoforms (that arise through alternative splicing etc.) testing them in high-throughput assays for DNA-binding, protein-binding, activation, and more.
March 26, 2025 at 6:38 PM
Reposted by Luke Lambourne
our work on the molecular differences between transcription factor isoforms is out now in Molecular Cell!

key point: 2/3rds of TF isos differ in properties like DNA binding & transcriptional activity

many are "negative regulators" & misexpressed in cancer

www.sciencedirect.com/science/arti...
March 26, 2025 at 5:11 PM
Reposted by Luke Lambourne
As the first measles death in the US since 2015--an unvaccinated child--is reported, let us read the thoughts of our new Secretary of Health and Human Services on this disease. www.reuters.com/world/us/fir... (Foreword to "The Measles Book", 2021)
February 26, 2025 at 5:48 PM
Reposted by Luke Lambourne
On Wednesday 2/26, I’ll be in Boston to give a Harvard Science Book Talk. I’ll have a marvelous relic of aerobiological history to unveil. Details here: www.harvard.com/event/carl-z... 3/5
www.harvard.com
February 19, 2025 at 5:46 PM
Reposted by Luke Lambourne
The STARLING has landed - excited to share new work from @bornanovak.bsky.social and @jefflotthammer.bsky.social in what is also Borna's first Bluesky post!

If you're at BPS, I'll be speaking about this this afternoon in IDP SG, and Borna and Jeff both have posters (Sunday B112 and Wed B152).
Excited to announce the newest member of the flock - STARLING (conSTruction of intrinsicAlly disoRdered proteins ensembles efficientLy vIa multi-dimeNsional Generative models).
www.biorxiv.org/content/10.1...
February 15, 2025 at 7:33 PM
Reposted by Luke Lambourne
Interested in learning about biases in protein-protein interface predictions with AlphaFold2? Check out our new review on this topic:

authors.elsevier.com/a/1kbSa_,2Bd...
authors.elsevier.com
February 14, 2025 at 6:20 PM
Reposted by Luke Lambourne
Btw, the abstract deadline has been extended to Jan 27!
January 14, 2025 at 10:08 PM
Reposted by Luke Lambourne
🧪 If you are a network (or network-curious!) biologist, please consider attending the upcoming CSHL Network Biology Meeting. Details + abstract deadline below!
January 14, 2025 at 8:34 PM
Reposted by Luke Lambourne
Can a single small molecule rescue the stability of nearly all mutations in a protein?
Our new preprint by Taylor Mighell
www.biorxiv.org/content/10.1...
thread on the other place: x.com/taylor_mighe...
A pharmacological chaperone stabilizer rescues the expression of the vast majority of pathogenic variants in a G protein-coupled receptor
Reduced protein stability is the most frequent mechanism by which rare missense variants cause disease. A promising therapeutic avenue for treating destabilizing variants is pharmacological chaperones...
www.biorxiv.org
December 3, 2024 at 9:40 AM